Skip to content

LSD research published in 2016

39 studies whose primary subject is LSD were published in 2016, up from 17 in 2015. Newest first. Back to the LSD overview

Studies

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.

Neuroscience & Biobehavioral Reviews December 2016 Rafael G. Dos Santos, Flávia L. Osório, José Alexandre S. Crippa et al.

Serotonergic hallucinogens produce alterations of perceptions, mood, and cognition, and have anxiolytic, antidepressant, and antiaddictive properties. These drugs act as agonists of frontocortical 5-HT2A receptors, but the neural basis of their effects are not well understood. Thus, we conducted a systematic review of neuroimaging studies analyzing the effects of serotonergic hallucinogens in...

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

International Journal of Molecular Sciences November 23, 2016 Danilo de Gregorio, Stefano Comai, Luca Posa et al. 125 citations

d-Lysergic Acid Diethylamide (LSD) is known for its hallucinogenic properties and psychotic-like symptoms, especially at high doses. It is indeed used as a pharmacological model of psychosis in preclinical research. The goal of this review was to understand the mechanism of action of psychotic-like effects of LSD. We searched Pubmed, Web of Science, Scopus, Google Scholar and articles’...

The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors.

Pharmacological Research November 2016 Danilo de Gregorio, Luca Posa, Rafael Ochoa-Sanchez et al.

d-lysergic diethylamide (LSD) is a hallucinogenic drug that interacts with the serotonin (5-HT) system binding to 5-HT1 and 5-HT2 receptors. Little is known about its potential interactions with the dopamine (DA) neurons of the ventral tegmental area (VTA). Using in-vivo electrophysiology in male adult rats, we evaluated the effects of cumulative doses of LSD on VTA DA neuronal activity,...

DOI: 10.1016/j.phrs.2016.08.022 (opens in new tab) Full text (opens in new tab) Serotonin 8-oh-dpat pubchem cid Apomorphine pubchem cid Dopamine +6

Role of psilocybin in the treatment of depression

Therapeutic Advances in Psychopharmacology October 27, 2016 Ananya Mahapatra, Rishi Gupta 37 citations

Psilocybin is a naturally occurring alkaloid, pharmacologically similar to the classic hallucinogen lysergic acid diethylamide (LSD). Although primarily used as a recreational drug or an entheogen in particular cultural settings, recent population based studies have shown that it does not lead to serious physical or mental health problems or dependent use. In view of recent work demonstrating...

Alterations of consciousness and mystical-type experiences after acute LSD in humans

Psychopharmacology October 7, 2016 Matthias E. Liechti, Patrick C. Dolder, Yasmin Schmid 203 citations

Mystical-type experiences were infrequent after LSD, possibly because of the set and setting used in the present study. LSD may produce greater or different alterations of consciousness at 200 μg (i.e., a dose that is currently used in psychotherapy in Switzerland) compared with 100 μg (i.e., a dose used in imaging studies). Ego dissolution may reflect plasma levels of LSD, whereas more...

Rehabilitating LSD history in postwar America: Dilworth Wayne Woolley and the serotonin hypothesis of mental illness

History of Science September 1, 2016 Kim Hewitt 2 citations

Revisiting the history of postwar LSD (lysergic acid diethylamide) research illuminates how the work of a chemist at the Rockefeller Institute contributed to the development of a biochemical paradigm for mental functioning. Dilworth Wayne Woolley proposed one of the first theories of the biochemistry of mental illness based on empirical evidence. His research with LSD and serotonin had...

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion

Journal of Vision September 1, 2016 Leor Roseman, Martin I. Sereno, Robert Leech et al. 4 citations

ABSTRACT Introduction: The question of how spatially-organized activity in the visual cortex behaves during eyes-closed, LSD-induced, visual psychedelic imagery has never been empirically addressed, although it has been proposed that under psychedelics the brain may function "as if" there is visual input when there is none (de Araujo, et al., 2012). We suspected that eyes-closed psychedelic...

DOI: 10.1167/16.12.133 (opens in new tab) Visual cortex Visual field Cortex anatomy Functional connectivity +1

LSD acutely impairs fear recognition and enhances emotional empathy and sociality

August 24, 2016 Patrick C. Dolder 12 citations

Lysergic acid diethylamide (LSD) is used recreationally and has been evaluated as an adjunct to psychotherapy to treat anxiety in patients with life-threatening illness.LSD is well-known to induce perceptual alterations, but unknown is whether LSD alters emotional processing in ways that can support psychotherapy.We investigated the acute effects of LSD on emotional processing using the Face...

Semantic activation in LSD: evidence from picture naming

Language, Cognition and Neuroscience August 11, 2016 Neiloufar Family, David W Vinson, Gabriella Vigliocco et al. 53 citations

Lysergic acid diethylamide (LSD) is a classic psychedelic drug that alters cognition in a characteristic way. It has been suggested that psychedelics expand the breadth of cognition via actions on the central nervous system. Previous work has shown changes in semantic processing under psilocybin (a related psychedelic to LSD) that are consistent with an increased spread of semantic activation....

DOI: 10.1080/23273798.2016.1217030 (opens in new tab) Natural language processing Cognitive psychology Linguistics

Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; A Review with Illustrative Case

Current Psychiatry Reviews August 10, 2016 Cornel N. Stanciu, Thomas M. Penders 3 citations

Hallucinogen Persistent Perception Disorder (HPPD) is considered an “uncommon” disorder described in association with use of hallucinogens such as LSD, mescaline and psilocybin. Despite multiple mentions of persistence of visual disturbances reported by users on online forums, clinicians may not be aware of this complication. There have been few descriptions of HPPD in association with use of...

Hallucinogen Use Disorders.

Child and Adolescent Psychiatric Clinics of North America July 2016 Rashad Hardaway, Jason Schweitzer, Joji Suzuki

Use of hallucinogenic substances as a public health concern has increased over the past decade. Among adolescents, there are increasing emergency department presentations for intoxication with these drugs, contrary to decreasing reported use of classical hallucinogens such as LSD. Academic and governmental groups have monitored use of hallucinogens, highlighting a notable change in perceptions...

From Psychiatry to Flower Power and Back Again: The Amazing Story of Lysergic Acid Diethylamide.

Assay and drug development technologies July 1, 2016 Hermann A M Mucke 3 citations

Among the psychedelic drugs that enjoyed a period of popularity in psychiatric research during the 1950s and 1960s, lysergic acid diethylamide (LSD) is the most prominent one. Psychiatrists of that time had seen LSD not only as a tool for psychotherapy but also as a potential therapeutic for anxiety, depression, alcohol abuse, autism, and even schizophrenia. When it became a quasi-religious...

1H and 13C NMR spectra of N6-allyl-6-norlysergic acid diethylamide (AL-LAD)

June 6, 2016 Darcy C. Burns, T. Burrow, S. J. Chapman

First reported (online early view): 6 Jun 2016 in: S.D. Brandt, P.V. Kavanagh, F. Westphal, S.P. Elliott, J. Wallach, T. Colestock, T.E. Burrow, S.J. Chapman, A. Stratford, D.E. Nichols, A.L. Halberstadt. Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2′S,4′S)-lysergic acid 2,4-dimethylazetidide (LSZ)....

Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ)

Drug Testing and Analysis June 6, 2016 Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal et al. 62 citations

Lysergic N,N-diethylamide (LSD) is perhaps one of the most intriguing psychoactive substances known and numerous analogs have been explored to a varying extent in previous decades. In 2013, N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ) have appeared on the ‘research chemicals’ / new psychoactive substances (NPS) market in both powdered...

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality

Neuropsychopharmacology June 1, 2016 Patrick C. Dolder, Yasmin Schmid, Felix Müller et al. 249 citations

Lysergic acid diethylamide (LSD) is used recreationally and has been evaluated as an adjunct to psychotherapy to treat anxiety in patients with life-threatening illness. LSD is well-known to induce perceptual alterations, but unknown is whether LSD alters emotional processing in ways that can support psychotherapy. We investigated the acute effects of LSD on emotional processing using the Face...

Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration

History of Psychiatry May 19, 2016 Matthew Oram 32 citations

Over the 1950s and early 1960s, the use of the hallucinogenic drug lysergic acid diethylamide (LSD) to facilitate psychotherapy was a promising field of psychiatric research in the USA. However, during the 1960s, research began to decline, before coming to a complete halt in the mid-1970s. This has commonly been explained through the increase in prohibitive federal regulations during the 1960s...

LSD-induced entropic brain activity predicts subsequent personality change.

Human Brain Mapping May 6, 2016 Alexander V. Lebedev, Mendel Kaelen, Martin Lövdén et al. 333 citations

Personality is known to be relatively stable throughout adulthood. Nevertheless, it has been shown that major life events with high personal significance, including experiences engendered by psychedelic drugs, can have an enduring impact on some core facets of personality. In the present, balanced-order, placebo-controlled study, we investigated biological predictors of post-lysergic acid...

DOI: 10.1002/hbm.23234 (opens in new tab) Full text (opens in new tab) Neuroplasticity Brain plasticity. Brain adaptability Neural flexibility +19

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.

Human Brain Mapping April 29, 2016 Leor Roseman, Martin I. Sereno, Robert Leech et al. 63 citations

The question of how spatially organized activity in the visual cortex behaves during eyes-closed, lysergic acid diethylamide (LSD)-induced "psychedelic imagery" (e.g., visions of geometric patterns and more complex phenomena) has never been empirically addressed, although it has been proposed that under psychedelics, with eyes-closed, the brain may function "as if" there is visual input when...

Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.

Current Biology April 13, 2016 Enzo Tagliazucchi, Leor Roseman, Mendel Kaelen et al. 531 citations

Lysergic acid diethylamide (LSD) is a non-selective serotonin-receptor agonist that was first synthesized in 1938 and identified as (potently) psychoactive in 1943. Psychedelics have been used by indigenous cultures for millennia [1]; however, because of LSD's unique potency and the timing of its discovery (coinciding with a period of major discovery in psychopharmacology), it is generally...

LSD modulates music-induced imagery via changes in parahippocampal connectivity.

European Neuropsychopharmacology April 12, 2016 Mendel Kaelen, Leor Roseman, Joshua Kahan et al. 143 citations

Psychedelic drugs such as lysergic acid diethylamide (LSD) were used extensively in psychiatry in the past and their therapeutic potential is beginning to be re-examined today. Psychedelic psychotherapy typically involves a patient lying with their eyes-closed during peak drug effects, while listening to music and being supervised by trained psychotherapists. In this context, music is...